Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 205.32 | 1,437 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 209.765 | 1,468 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7 | 249.05 | 1,743 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 12 | 185.9442 | 2,231 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 213.625 | 3,204 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 217.9 | 3,268 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 31 | 183.16 | 5,678 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 30 | 208.6913 | 6,261 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29 | 223.9374 | 6,494 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 39 | 171.79 | 6,700 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 54 | 152.2129 | 8,219 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 41 | 213.7994 | 8,766 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 54 | 167.63 | 9,052 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 53 | 186.3171 | 9,875 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 43 | 247.0342 | 10,622 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 206.9321 | 10,760 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 212.0414 | 11,026 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 53 | 214.7223 | 11,380 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 56 | 205.6 | 11,514 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 82 | 174.6698 | 14,323 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 109 | 142.8575 | 15,571 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 93 | 168.7825 | 15,697 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 95 | 188.8359 | 17,939 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 100 | 185.865 | 18,586 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 205.32 | 19,095 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 209.765 | 19,508 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 115 | 186.593 | 21,458 | I |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 100 | 219.9 | 21,990 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 107 | 226.971 | 24,286 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 140 | 173.7481 | 24,325 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 100 | 246.8805 | 24,688 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 100 | 248.23 | 24,823 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 100 | 259.07 | 25,907 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 146 | 185.9442 | 27,148 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 275.24 | 27,524 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 100 | 276.19 | 27,619 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 276.4 | 27,640 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 153 | 181.93 | 27,835 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 100 | 284.65 | 28,465 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 100 | 285.28 | 28,528 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 100 | 287.86 | 28,786 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 141 | 216.6683 | 30,550 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 116 | 264.7343 | 30,709 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 135 | 242 | 32,670 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 176 | 187.2439 | 32,955 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 265 | 136.1805 | 36,088 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 252 | 145.9775 | 36,786 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 242 | 153.2523 | 37,087 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 143 | 263.0816 | 37,621 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 213.625 | 39,521 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 176 | 228.7893 | 40,267 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 217.9 | 40,312 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 311 | 136.9089 | 42,579 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 185 | 242 | 44,770 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 299 | 154.5969 | 46,224 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 178 | 263.3133 | 46,870 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 250 | 189.6978 | 47,424 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 193 | 248.4887 | 47,958 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 200 | 248.425 | 49,685 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 200 | 248.4508 | 49,690 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 200 | 248.58 | 49,716 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 229 | 217.9078 | 49,901 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 200 | 259.11 | 51,822 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 200 | 259.13 | 51,826 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 390 | 137.6855 | 53,697 | I |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 224 | 243.245 | 54,487 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 280.41 | 56,082 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 281.79 | 56,358 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 283.61 | 56,722 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 427 | 140.9024 | 60,165 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 350 | 173.2016 | 60,621 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 369 | 183.16 | 67,586 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 308 | 221.2418 | 68,142 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 316 | 229.8647 | 72,637 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 388 | 187.2707 | 72,661 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 415 | 175.7185 | 72,923 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 274 | 266.9052 | 73,132 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 274 | 266.9052 | 73,132 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 300 | 245.6867 | 73,706 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 405 | 187.345 | 75,875 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 370 | 208.6913 | 77,216 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 507 | 152.48 | 77,307 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 352 | 220.6546 | 77,670 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 537 | 145.4592 | 78,112 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 360 | 219.8652 | 79,151 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 461 | 171.79 | 79,195 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 361 | 221.7787 | 80,062 | I |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 300 | 267.0733 | 80,122 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 300 | 268.99 | 80,697 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 375 | 216.0836 | 81,031 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 363 | 223.9374 | 81,289 | I |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 300 | 288.91 | 86,673 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 351 | 264.8908 | 92,977 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 646 | 152.2129 | 98,330 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 361 | 277.77 | 100,275 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 446 | 224.9117 | 100,311 | I |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 407 | 247.7582 | 100,838 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 683 | 153.9736 | 105,164 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 435 | 244.0066 | 106,143 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 579 | 183.3999 | 106,189 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)